NLS Pharmaceutics AG (NLSPW) — Financial Flexibility Index
NLS Pharmaceutics AG (NLSPW) has a Financial Flexibility Index of -1.43x as of September 2025. Free cash flow of $-2.07 Million (operating CF $-2.07 Million minus capex $0.00) represents -1% of total liabilities ($1.46 Million). Also explore NLS Pharmaceutics AG net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
NLS Pharmaceutics AG Financial Flexibility Index (2017–2024)
Historical Financial Flexibility Index trend for NLS Pharmaceutics AG across 8 annual periods. See debt-free asset ratio of NLS Pharmaceutics AG to measure how much of total assets are equity-financed.
Annual Financial Flexibility Index for NLS Pharmaceutics AG (2017–2024)
Year-by-year free cash flow to debt coverage for NLS Pharmaceutics AG. For the full company profile including market capitalisation, see market cap of NLS Pharmaceutics AG.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -5.16x | $-4.26 Million | $-4.27 Million | $826.76K | ▼ -468.8% |
| 2023 | -0.91x | $-9.68 Million | $-9.68 Million | $10.68 Million | ▲ +58.9% |
| 2022 | -2.21x | $-13.24 Million | $-13.88 Million | $6.00 Million | ▲ +22.6% |
| 2021 | -2.85x | $-14.90 Million | $-14.94 Million | $5.22 Million | ▼ -3887.3% |
| 2020 | -0.07x | $-729.38K | $-729.39K | $10.20 Million | ▼ -158.6% |
| 2019 | -0.03x | $-190.01K | $-190.01K | $6.87 Million | ▲ +90.9% |
| 2018 | -0.31x | $-2.73 Million | $-2.73 Million | $8.96 Million | ▲ +43.8% |
| 2017 | -0.54x | $-5.43 Million | $-5.43 Million | $10.01 Million | — |